 | • レポートコード：D005-08451 • 出版社/出版日：GlobalInfoResearch / 2020年5月22日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、136ページ • 納品方法：Eメール • 産業分類：医療・製薬 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、免疫チェックポイント阻害剤の世界市場を広く調査・分析し、今後の市場展望をまとめております。免疫チェックポイント阻害剤の種類別市場規模（CTLA4、PD1、その他）、用途別市場規模（医療、実験、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Advaxis、Incyte Corporation、Bristol Myers Squibb、Agenus、Genocea、Amgen、Kite Pharma、Genentech、Faron Pharmaceuticals、Innate Pharma、TG Therapeutics、MacroGenics、Sorrento Therapeutics、Merck、NewLink Genetics Corp ・地域別グローバル市場分析 2015年-2020年 ・免疫チェックポイント阻害剤の北米市場（アメリカ、カナダ、メキシコ） ・免疫チェックポイント阻害剤のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・免疫チェックポイント阻害剤のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・免疫チェックポイント阻害剤の南米市場（ブラジル、アルゼンチン） ・免疫チェックポイント阻害剤の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：CTLA4、PD1、その他 ・用途別分析：医療、実験、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Immune Check Point Inhibitor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Immune Check Point Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Immune Check Point Inhibitor market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Immune Check Point Inhibitor market has been segmented into
CTLA 4
PD 1
Others
By Application, Immune Check Point Inhibitor has been segmented into:
Medical Care
Experiment
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Immune Check Point Inhibitor market presented in the report. This section sheds light on the sales growth of different regional and country-level Immune Check Point Inhibitor markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Immune Check Point Inhibitor market.
The report offers in-depth assessment of the growth and other aspects of the Immune Check Point Inhibitor market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Immune Check Point Inhibitor Market Share Analysis
Immune Check Point Inhibitor competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Immune Check Point Inhibitor sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Immune Check Point Inhibitor sales, revenue and market share for each player covered in this report.
The major players covered in Immune Check Point Inhibitor are:
Advaxis
Incyte Corporation
Bristol Myers Squibb
Agenus
Genocea
Amgen
Kite Pharma
Genentech
Faron Pharmaceuticals
Innate Pharma
TG Therapeutics
MacroGenics
Sorrento Therapeutics
Merck
NewLink Genetics Corp
Among other players domestic and global, Immune Check Point Inhibitor market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Immune Check Point Inhibitor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Immune Check Point Inhibitor, with price, sales, revenue and global market share of Immune Check Point Inhibitor in 2018 and 2019.
Chapter 3, the Immune Check Point Inhibitor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Immune Check Point Inhibitor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Immune Check Point Inhibitor market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Immune Check Point Inhibitor sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Immune Check Point Inhibitor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Immune Check Point Inhibitor Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 CTLA 4
1.2.3 PD 1
1.2.4 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Immune Check Point Inhibitor Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Medical Care
1.3.3 Experiment
1.3.4 Others
1.4 Overview of Global Immune Check Point Inhibitor Market
1.4.1 Global Immune Check Point Inhibitor Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Advaxis
2.1.1 Advaxis Details
2.1.2 Advaxis Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Advaxis SWOT Analysis
2.1.4 Advaxis Product and Services
2.1.5 Advaxis Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Incyte Corporation
2.2.1 Incyte Corporation Details
2.2.2 Incyte Corporation Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Incyte Corporation SWOT Analysis
2.2.4 Incyte Corporation Product and Services
2.2.5 Incyte Corporation Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Bristol Myers Squibb
2.3.1 Bristol Myers Squibb Details
2.3.2 Bristol Myers Squibb Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Bristol Myers Squibb SWOT Analysis
2.3.4 Bristol Myers Squibb Product and Services
2.3.5 Bristol Myers Squibb Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Agenus
2.4.1 Agenus Details
2.4.2 Agenus Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Agenus SWOT Analysis
2.4.4 Agenus Product and Services
2.4.5 Agenus Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Genocea
2.5.1 Genocea Details
2.5.2 Genocea Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Genocea SWOT Analysis
2.5.4 Genocea Product and Services
2.5.5 Genocea Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Amgen
2.6.1 Amgen Details
2.6.2 Amgen Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Amgen SWOT Analysis
2.6.4 Amgen Product and Services
2.6.5 Amgen Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Kite Pharma
2.7.1 Kite Pharma Details
2.7.2 Kite Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Kite Pharma SWOT Analysis
2.7.4 Kite Pharma Product and Services
2.7.5 Kite Pharma Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Genentech
2.8.1 Genentech Details
2.8.2 Genentech Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Genentech SWOT Analysis
2.8.4 Genentech Product and Services
2.8.5 Genentech Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 Faron Pharmaceuticals
2.9.1 Faron Pharmaceuticals Details
2.9.2 Faron Pharmaceuticals Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 Faron Pharmaceuticals SWOT Analysis
2.9.4 Faron Pharmaceuticals Product and Services
2.9.5 Faron Pharmaceuticals Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Innate Pharma
2.10.1 Innate Pharma Details
2.10.2 Innate Pharma Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Innate Pharma SWOT Analysis
2.10.4 Innate Pharma Product and Services
2.10.5 Innate Pharma Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 TG Therapeutics
2.11.1 TG Therapeutics Details
2.11.2 TG Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 TG Therapeutics SWOT Analysis
2.11.4 TG Therapeutics Product and Services
2.11.5 TG Therapeutics Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 MacroGenics
2.12.1 MacroGenics Details
2.12.2 MacroGenics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 MacroGenics SWOT Analysis
2.12.4 MacroGenics Product and Services
2.12.5 MacroGenics Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.13 Sorrento Therapeutics
2.13.1 Sorrento Therapeutics Details
2.13.2 Sorrento Therapeutics Major Business and Total Revenue (Financial Highlights) Analysis
2.13.3 Sorrento Therapeutics SWOT Analysis
2.13.4 Sorrento Therapeutics Product and Services
2.13.5 Sorrento Therapeutics Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.14 Merck
2.14.1 Merck Details
2.14.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.14.3 Merck SWOT Analysis
2.14.4 Merck Product and Services
2.14.5 Merck Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.15 NewLink Genetics Corp
2.15.1 NewLink Genetics Corp Details
2.15.2 NewLink Genetics Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.15.3 NewLink Genetics Corp SWOT Analysis
2.15.4 NewLink Genetics Corp Product and Services
2.15.5 NewLink Genetics Corp Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Immune Check Point Inhibitor Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Immune Check Point Inhibitor Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Immune Check Point Inhibitor Manufacturer Market Share in 2019
3.3.2 Top 6 Immune Check Point Inhibitor Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Immune Check Point Inhibitor Sales, Revenue and Market Share by Regions
4.1.1 Global Immune Check Point Inhibitor Sales and Market Share by Regions (2015-2020)
4.1.2 Global Immune Check Point Inhibitor Revenue and Market Share by Regions (2015-2020)
4.2 North America Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
4.3 Europe Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
4.5 South America Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Immune Check Point Inhibitor Sales, Revenue and Market Share by Country
5.1.1 North America Immune Check Point Inhibitor Sales and Market Share by Country (2015-2020)
5.1.2 North America Immune Check Point Inhibitor Revenue and Market Share by Country (2015-2020)
5.2 United States Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
5.3 Canada Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
5.4 Mexico Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Immune Check Point Inhibitor Sales, Revenue and Market Share by Country
6.1.1 Europe Immune Check Point Inhibitor Sales and Market Share by Country (2015-2020)
6.1.2 Europe Immune Check Point Inhibitor Revenue and Market Share by Country (2015-2020)
6.2 Germany Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
6.3 UK Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
6.4 France Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
6.5 Russia Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
6.6 Italy Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Immune Check Point Inhibitor Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Immune Check Point Inhibitor Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Immune Check Point Inhibitor Revenue and Market Share by Regions (2015-2020)
7.2 China Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
7.3 Japan Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
7.4 Korea Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
7.5 India Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
7.7 Australia Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Immune Check Point Inhibitor Sales, Revenue and Market Share by Country
8.1.1 South America Immune Check Point Inhibitor Sales and Market Share by Country (2015-2020)
8.1.2 South America Immune Check Point Inhibitor Revenue and Market Share by Country (2015-2020)
8.2 Brazil Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
8.3 Argentina Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Immune Check Point Inhibitor Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Immune Check Point Inhibitor Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Immune Check Point Inhibitor Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
9.3 Turkey Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
9.4 Egypt Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
9.5 South Africa Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Immune Check Point Inhibitor Sales and Market Share by Type (2015-2020)
10.2 Global Immune Check Point Inhibitor Revenue and Market Share by Type (2015-2020)
10.3 Global Immune Check Point Inhibitor Price by Type (2015-2020)
11 Global Immune Check Point Inhibitor Market Segment by Application
11.1 Global Immune Check Point Inhibitor Sales Market Share by Application (2015-2020)
11.2 Global Immune Check Point Inhibitor Revenue Market Share by Application (2015-2020)
11.3 Global Immune Check Point Inhibitor Price by Application (2015-2020)
12 Market Forecast
12.1 Global Immune Check Point Inhibitor Sales, Revenue and Growth Rate (2021-2025)
12.2 Immune Check Point Inhibitor Market Forecast by Regions (2021-2025)
12.2.1 North America Immune Check Point Inhibitor Market Forecast (2021-2025)
12.2.2 Europe Immune Check Point Inhibitor Market Forecast (2021-2025)
12.2.3 Asia-Pacific Immune Check Point Inhibitor Market Forecast (2021-2025)
12.2.4 South America Immune Check Point Inhibitor Market Forecast (2021-2025)
12.2.5 Middle East & Africa Immune Check Point Inhibitor Market Forecast (2021-2025)
12.3 Immune Check Point Inhibitor Market Forecast by Type (2021-2025)
12.3.1 Global Immune Check Point Inhibitor Sales Forecast by Type (2021-2025)
12.3.2 Global Immune Check Point Inhibitor Market Share Forecast by Type (2021-2025)
12.4 Immune Check Point Inhibitor Market Forecast by Application (2021-2025)
12.4.1 Global Immune Check Point Inhibitor Sales Forecast by Application (2021-2025)
12.4.2 Global Immune Check Point Inhibitor Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Immune Check Point Inhibitor Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Immune Check Point Inhibitor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Immune Check Point Inhibitor Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Advaxis Basic Information, Manufacturing Base and Competitors
Table 8. Advaxis Immune Check Point Inhibitor Major Business
Table 9. Advaxis Immune Check Point Inhibitor Total Revenue (USD Million) (2018-2019)
Table 10. Advaxis SWOT Analysis
Table 11. Advaxis Immune Check Point Inhibitor Product and Services
Table 12. Advaxis Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Incyte Corporation Basic Information, Manufacturing Base and Competitors
Table 14. Incyte Corporation Immune Check Point Inhibitor Major Business
Table 15. Incyte Corporation Immune Check Point Inhibitor Total Revenue (USD Million) (2018-2019)
Table 16. Incyte Corporation SWOT Analysis
Table 17. Incyte Corporation Immune Check Point Inhibitor Product and Services
Table 18. Incyte Corporation Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Bristol Myers Squibb Basic Information, Manufacturing Base and Competitors
Table 20. Bristol Myers Squibb Immune Check Point Inhibitor Major Business
Table 21. Bristol Myers Squibb Immune Check Point Inhibitor Total Revenue (USD Million) (2018-2019)
Table 22. Bristol Myers Squibb SWOT Analysis
Table 23. Bristol Myers Squibb Immune Check Point Inhibitor Product and Services
Table 24. Bristol Myers Squibb Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Agenus Basic Information, Manufacturing Base and Competitors
Table 26. Agenus Immune Check Point Inhibitor Major Business
Table 27. Agenus Immune Check Point Inhibitor Total Revenue (USD Million) (2018-2019)
Table 28. Agenus SWOT Analysis
Table 29. Agenus Immune Check Point Inhibitor Product and Services
Table 30. Agenus Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Genocea Basic Information, Manufacturing Base and Competitors
Table 32. Genocea Immune Check Point Inhibitor Major Business
Table 33. Genocea Immune Check Point Inhibitor Total Revenue (USD Million) (2018-2019)
Table 34. Genocea SWOT Analysis
Table 35. Genocea Immune Check Point Inhibitor Product and Services
Table 36. Genocea Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Amgen Basic Information, Manufacturing Base and Competitors
Table 38. Amgen Immune Check Point Inhibitor Major Business
Table 39. Amgen Immune Check Point Inhibitor Total Revenue (USD Million) (2018-2019)
Table 40. Amgen SWOT Analysis
Table 41. Amgen Immune Check Point Inhibitor Product and Services
Table 42. Amgen Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Kite Pharma Basic Information, Manufacturing Base and Competitors
Table 44. Kite Pharma Immune Check Point Inhibitor Major Business
Table 45. Kite Pharma Immune Check Point Inhibitor Total Revenue (USD Million) (2018-2019)
Table 46. Kite Pharma SWOT Analysis
Table 47. Kite Pharma Immune Check Point Inhibitor Product and Services
Table 48. Kite Pharma Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Genentech Basic Information, Manufacturing Base and Competitors
Table 50. Genentech Immune Check Point Inhibitor Major Business
Table 51. Genentech Immune Check Point Inhibitor Total Revenue (USD Million) (2018-2019)
Table 52. Genentech SWOT Analysis
Table 53. Genentech Immune Check Point Inhibitor Product and Services
Table 54. Genentech Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Faron Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Faron Pharmaceuticals Immune Check Point Inhibitor Major Business
Table 57. Faron Pharmaceuticals Immune Check Point Inhibitor Total Revenue (USD Million) (2018-2019)
Table 58. Faron Pharmaceuticals SWOT Analysis
Table 59. Faron Pharmaceuticals Immune Check Point Inhibitor Product and Services
Table 60. Faron Pharmaceuticals Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 61. Innate Pharma Basic Information, Manufacturing Base and Competitors
Table 62. Innate Pharma Immune Check Point Inhibitor Major Business
Table 63. Innate Pharma Immune Check Point Inhibitor Total Revenue (USD Million) (2018-2019)
Table 64. Innate Pharma SWOT Analysis
Table 65. Innate Pharma Immune Check Point Inhibitor Product and Services
Table 66. Innate Pharma Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 67. TG Therapeutics Basic Information, Manufacturing Base and Competitors
Table 68. TG Therapeutics Immune Check Point Inhibitor Major Business
Table 69. TG Therapeutics Immune Check Point Inhibitor Total Revenue (USD Million) (2018-2019)
Table 70. TG Therapeutics SWOT Analysis
Table 71. TG Therapeutics Immune Check Point Inhibitor Product and Services
Table 72. TG Therapeutics Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 73. MacroGenics Basic Information, Manufacturing Base and Competitors
Table 74. MacroGenics Immune Check Point Inhibitor Major Business
Table 75. MacroGenics Immune Check Point Inhibitor Total Revenue (USD Million) (2018-2019)
Table 76. MacroGenics SWOT Analysis
Table 77. MacroGenics Immune Check Point Inhibitor Product and Services
Table 78. MacroGenics Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 79. Sorrento Therapeutics Basic Information, Manufacturing Base and Competitors
Table 80. Sorrento Therapeutics Immune Check Point Inhibitor Major Business
Table 81. Sorrento Therapeutics Immune Check Point Inhibitor Total Revenue (USD Million) (2018-2019)
Table 82. Sorrento Therapeutics SWOT Analysis
Table 83. Sorrento Therapeutics Immune Check Point Inhibitor Product and Services
Table 84. Sorrento Therapeutics Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 85. Merck Basic Information, Manufacturing Base and Competitors
Table 86. Merck Immune Check Point Inhibitor Major Business
Table 87. Merck Immune Check Point Inhibitor Total Revenue (USD Million) (2018-2019)
Table 88. Merck SWOT Analysis
Table 89. Merck Immune Check Point Inhibitor Product and Services
Table 90. Merck Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 91. NewLink Genetics Corp Basic Information, Manufacturing Base and Competitors
Table 92. NewLink Genetics Corp Immune Check Point Inhibitor Major Business
Table 93. NewLink Genetics Corp Immune Check Point Inhibitor Total Revenue (USD Million) (2018-2019)
Table 94. NewLink Genetics Corp SWOT Analysis
Table 95. NewLink Genetics Corp Immune Check Point Inhibitor Product and Services
Table 96. NewLink Genetics Corp Immune Check Point Inhibitor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 97. Global Immune Check Point Inhibitor Sales by Manufacturer (2018-2019) (K Pcs)
Table 98. Global Immune Check Point Inhibitor Revenue by Manufacturer (2018-2019) (USD Million)
Table 99. Global Immune Check Point Inhibitor Sales by Regions (2015-2020) (K Pcs)
Table 100. Global Immune Check Point Inhibitor Sales Market Share by Regions (2015-2020)
Table 101. Global Immune Check Point Inhibitor Revenue by Regions (2015-2020) (USD Million)
Table 102. North America Immune Check Point Inhibitor Sales by Countries (2015-2020) (K Pcs)
Table 103. North America Immune Check Point Inhibitor Sales Market Share by Countries (2015-2020)
Table 104. North America Immune Check Point Inhibitor Revenue by Countries (2015-2020) (USD Million)
Table 105. North America Immune Check Point Inhibitor Revenue Market Share by Countries (2015-2020)
Table 106. Europe Immune Check Point Inhibitor Sales by Countries (2015-2020) (K Pcs)
Table 107. Europe Immune Check Point Inhibitor Sales Market Share by Countries (2015-2020)
Table 108. Europe Immune Check Point Inhibitor Revenue by Countries (2015-2020) (USD Million)
Table 109. Asia-Pacific Immune Check Point Inhibitor Sales by Regions (2015-2020) (K Pcs)
Table 110. Asia-Pacific Immune Check Point Inhibitor Sales Market Share by Regions (2015-2020)
Table 111. Asia-Pacific Immune Check Point Inhibitor Revenue by Regions (2015-2020) (USD Million)
Table 112. South America Immune Check Point Inhibitor Sales by Countries (2015-2020) (K Pcs)
Table 113. South America Immune Check Point Inhibitor Sales Market Share by Countries (2015-2020)
Table 114. South America Immune Check Point Inhibitor Revenue by Countries (2015-2020) (USD Million)
Table 115. South America Immune Check Point Inhibitor Revenue Market Share by Countries (2015-2020)
Table 116. Middle East & Africa Immune Check Point Inhibitor Sales by Countries (2015-2020) (K Pcs)
Table 117. Middle East & Africa Immune Check Point Inhibitor Sales Market Share by Countries (2015-2020)
Table 118. Middle East & Africa Immune Check Point Inhibitor Revenue by Countries (2015-2020) (USD Million)
Table 119. Middle East & Africa Immune Check Point Inhibitor Revenue Market Share by Countries (2015-2020)
Table 120. Global Immune Check Point Inhibitor Sales by Type (2015-2020) (K Pcs)
Table 121. Global Immune Check Point Inhibitor Sales Share by Type (2015-2020)
Table 122. Global Immune Check Point Inhibitor Revenue by Type (2015-2020) (USD Million)
Table 123. Global Immune Check Point Inhibitor Revenue Share by Type (2015-2020)
Table 124. Global Immune Check Point Inhibitor Sales by Application (2015-2020) (K Pcs)
Table 125. Global Immune Check Point Inhibitor Sales Share by Application (2015-2020)
Table 126. Global Immune Check Point Inhibitor Sales Forecast by Regions (2021-2025) (K Pcs)
Table 127. Global Immune Check Point Inhibitor Market Share Forecast by Regions (2021-2025)
Table 128. Global Immune Check Point Inhibitor Sales Forecast by Type (2021-2025) (K Pcs)
Table 129. Global Immune Check Point Inhibitor Market Share Forecast by Type (2021-2025)
Table 130. Global Immune Check Point Inhibitor Sales Forecast by Application (2021-2025)
Table 131. Global Immune Check Point Inhibitor Market Share Forecast by Application (2021-2025)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Immune Check Point Inhibitor Picture
Figure 2. Global Sales Market Share of Immune Check Point Inhibitor by Type in 2019
Figure 3. CTLA 4 Picture
Figure 4. PD 1 Picture
Figure 5. Others Picture
Figure 6. Immune Check Point Inhibitor Sales Market Share by Application in 2018
Figure 7. Medical Care Picture
Figure 8. Experiment Picture
Figure 9. Others Picture
Figure 10. Global Immune Check Point Inhibitor Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Immune Check Point Inhibitor Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Immune Check Point Inhibitor Sales Market Share by Manufacturer in 2019
Figure 31. Global Immune Check Point Inhibitor Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Immune Check Point Inhibitor Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Immune Check Point Inhibitor Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 36. Global Immune Check Point Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Immune Check Point Inhibitor Revenue Market Share by Regions (2015-2020)
Figure 38. Global Immune Check Point Inhibitor Revenue Market Share by Regions in 2018
Figure 39. North America Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
Figure 40. Europe Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
Figure 42. South America Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Immune Check Point Inhibitor Sales and Growth Rate (2015-2020)
Figure 44. North America Immune Check Point Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Immune Check Point Inhibitor Sales Market Share by Countries (2015-2020)
Figure 46. North America Immune Check Point Inhibitor Sales Market Share by Countries in 2018
Figure 47. North America Immune Check Point Inhibitor Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Immune Check Point Inhibitor Revenue Market Share by Countries in 2018
Figure 49. United States Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 50. Canada Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 51. Mexico Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 52. Europe Immune Check Point Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Immune Check Point Inhibitor Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Immune Check Point Inhibitor Revenue Market Share by Countries in 2019
Figure 55. Germany Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 56. UK Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 57. France Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 58. Russia Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 59. Italy Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 60. Asia-Pacific Immune Check Point Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Immune Check Point Inhibitor Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Immune Check Point Inhibitor Revenue Market Share by Regions 2019
Figure 63. China Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 64. Japan Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 65. Korea Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 66. India Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 67. Southeast Asia Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 68. South America Immune Check Point Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Immune Check Point Inhibitor Sales Market Share by Countries in 2019
Figure 70. South America Immune Check Point Inhibitor Revenue Market Share by Countries in 2019
Figure 71. Brazil Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 72. Argentina Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 73. Middle East and Africa Immune Check Point Inhibitor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Immune Check Point Inhibitor Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Immune Check Point Inhibitor Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Immune Check Point Inhibitor Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 78. Egypt Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 79. Turkey Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 80. South Africa Immune Check Point Inhibitor Sales and Growth Rate (2015-2020) (K Pcs)
Figure 81. Global Immune Check Point Inhibitor Sales and Growth Rate (2021-2025) (K Pcs)
Figure 82. Global Immune Check Point Inhibitor Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Immune Check Point Inhibitor Market Forecast (2021-2025) (K Pcs)
Figure 84. Europe Sales Immune Check Point Inhibitor Market Forecast (2021-2025) (K Pcs)
Figure 85. Asia-Pacific Sales Immune Check Point Inhibitor Market Forecast (2021-2025) (K Pcs)
Figure 86. South America Sales Immune Check Point Inhibitor Market Forecast (2021-2025) (K Pcs)
Figure 87. Middle East & Africa Sales Immune Check Point Inhibitor Market Forecast (2021-2025) (K Pcs)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
免疫用BCGの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Immune BCG market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Immune BCG market report provides …- サイトカイン阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Cytokine Inhibitor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Cytokine Inhibitor market …
- B細胞阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global B-Cell Inhibitor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The B-Cell Inhibitor market repo…
- プラスミノーゲン活性化因子阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Plasminogen Activator Inhibitor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Plasminogen A…
- イミダゾール誘導体阻害剤の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Imidazoline Derivative Inhibitor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Imidazoline …